Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

F/m Emerald Life Sciences Innovation ETF LFSC

Full chart Compare
Set alert

Price alert · LFSC

All alert types
45.75 USD +1.67 (+3.79%)

Nov 4, 2026, 1:43 PM EST

44.76 Day range 45.78
31.02 52-week range 48.78
YTD
+24.93%
1 year
+43.91%

F/M Emerald Life Sciences Innovation ETF

Issuer
Emerald
Asset class
Equity
Expense ratio
0.79%
Assets under management
$121.00M
NAV
43.26
Holdings
0
Inception
2024-10-30
Top 10 weight
55.89%

Top holdings

  1. REPL Replimune Group Inc 10.44%
  2. LIVN LivaNova PLC 6.86%
  3. COGT Cogent Biosciences Inc 5.96%
  4. TVTX Travere Therapeutics Inc 5.65%
  5. GH Guardant Health Inc 5.38%
  6. BLLN Billiontoone Inc 4.87%
  7. CORT Corcept Therapeutics Inc 4.61%
  8. SYRE Spyre Therapeutics Inc 4.17%
  9. MANE VeraDermics Inc 4.03%
  10. UTHR United Therapeutics Corp 3.94%
  11. MIRM Mirum Pharmaceuticals Inc 3.52%
  12. CYTK Cytokinetics Inc 3.18%
  13. TMDX TransMedics Group Inc 2.75%
  14. ICUI ICU Medical Inc 2.68%
  15. SVRA Savara Inc 2.62%
  16. AXSM Axsome Therapeutics Inc 2.61%
  17. PVLA Palvella Therapeutics Inc 2.24%
  18. TRVI Trevi Therapeutics Inc 2.24%
  19. TWST Twist Bioscience Corp 2.12%
  20. CBLL Ceribell Inc 2.12%
  21. PRAX Praxis Precision Medicines Inc 1.90%
  22. NKTR Nektar Therapeutics 1.63%
  23. VRDN Viridian Therapeutics Inc 1.58%
  24. DNTH Dianthus Therapeutics Inc 1.53%
  25. CRVS Corvus Pharmaceuticals Inc 1.38%

Sector weights

  • Healthcare 100.00%

Country weights

  • United States 100.00%

Updated 2026-11-04

Held by funds

1 US ETFs and mutual funds hold LFSC · largest positions

Funds holding LFSC, by value held
FundValue heldWeight in fund
NMBL $852.26K3.61%

Top institutional holders

Top institutional holders
Holder% heldSharesValueReported
Financial Investors Tr-Emerald Growth Fund92.29%2,000,00047.48MOct 30, 2024